Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucosal-associated invariant T cells for cancer immunotherapy
Yan-Ruide Li, Kuangyi Zhou, Matthew Wilson, et al.
Molecular Therapy (2022) Vol. 31, Iss. 3, pp. 631-646
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
Yan-Ruide Li, Ying Fang, Zibai Lyu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Yan-Ruide Li, Tyler Halladay, Lili Yang
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 23
Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?
Caroline Lonez, Eytan Breman
Cells (2024) Vol. 13, Iss. 2, pp. 146-146
Open Access | Times Cited: 18
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1849-1874
Open Access | Times Cited: 18
Boosting CAR-T cell therapy through vaccine synergy
Yan-Ruide Li, Zibai Lyu, Xinyuan Shen, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 2
Advancing cell-based cancer immunotherapy through stem cell engineering
Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, et al.
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 592-610
Open Access | Times Cited: 41
The future of affordable cancer immunotherapy
Niels Schaft, Jan Dörrie, Gerold Schuler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
New cell sources for CAR-based immunotherapy
Marzieh Mazinani, Fatemeh Rahbarizadeh
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Biological functions and therapeutic applications of human mucosal-associated invariant T cells
Ying Fang, Yuning Chen, Shaoqiang Niu, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy
Zixin Lv, Fei‐Fei Luo, Yiwei Chu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Mucosal-associated invariant T cells in cancer: dual roles, complex interactions and therapeutic potential
Mesut Yiğit, Omer Faruk Basoglu, Derya Unutmaz
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 5
T cell landscape in the microenvironment of human solid tumors
Enrico Maggi, Enrico Munari, Nadine Landolina, et al.
Immunology Letters (2024) Vol. 270, pp. 106942-106942
Closed Access | Times Cited: 5
Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients
Antonia Rotolo, Eoin C. Whelan, Matthew J. Atherton, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 10, pp. 101241-101241
Open Access | Times Cited: 12
Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy
Yingfeng Zhang, Yuanyuan He, Chenyi Dai, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 9, pp. 100843-100843
Open Access | Times Cited: 4
Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context
Valentine Wang, Barbara Savoldo, J. Guimarães, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
The clinical landscape of CAR-engineered unconventional T cells
Yan-Ruide Li, Yichen Zhu, Yuning Chen, et al.
Trends in cancer (2025)
Open Access
The microbiota shapes the life trajectory of mucosal-associated invariant T cells
Yan-Ruide Li, Xinyuan Shen, Yichen Zhu, et al.
Trends in Microbiology (2025)
Open Access
Graft-versus-Host Disease Modulation by Innate T Cells
Ying Fang, Yichen Zhu, Adam Kramer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4084-4084
Open Access | Times Cited: 10
Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review
Chaozhi Tang, Yuling Zhang
Pathology - Research and Practice (2024) Vol. 262, pp. 155518-155518
Closed Access | Times Cited: 3
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Leveraging machine learning for integrative analysis of T-cell receptor repertoires in colorectal cancer: Insights into MAIT cell dynamics and risk assessment
Romi Goldner Kabeli, Ben Boursi, Alona Zilberberg, et al.
Translational Oncology (2025) Vol. 55, pp. 102358-102358
Closed Access
Tuning CAR T-cell therapies for efficacy and reduced toxicity
Danielle Blud, Patricia Rubio-Reyes, Rachel Perret, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 333-344
Closed Access | Times Cited: 3
Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy
Frankie Chi Fat Ko, Sheng Yan, Ka Wai Lee, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 902-902
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top